Renowned Israeli VC Jon Medved, diagnosed with ALS, supports technology aimed at enhancing his quality of life.

Jon Medved's Retirement: Venture capitalist Jon Medved announced his immediate retirement from OurCrowd after being diagnosed with Amyotrophic Lateral Sclerosis (ALS), a debilitating disease that affects motor neurons and leads to loss of muscle control.

Impact on Israel's Startup Ecosystem: Despite the challenges posed by the ongoing conflict in Gaza, Israel's startup ecosystem remains robust, with significant investments and a growing number of unicorns, showcasing its strength in various tech sectors.

Personal Connection to Health Tech: Medved's diagnosis has made him personally invested in health tech innovations, including the development of a digital avatar that preserves his voice and mannerisms, created in collaboration with startups focused on ALS.

Continued Contribution: Although stepping back from his role, Medved expresses a desire to remain active in the startup community and contribute to the ecosystem, emphasizing the importance of health tech in improving quality of life for those with chronic conditions.